How I Do It: Temporary RVAD Placed at the Time of Implantation of a HeartMate II LVAD
AbstractLeft ventricular assist devices (LVAD) are increasingly used to support patients as they await heart transplantation and as destination therapy for patients with end-stage cardiac failure. While the methods of LVAD implantation have become fairly standardized, early postoperative management of patients receiving these devices remains challenging. One issue that has plagued surgeons, cardiologists, and intensivists caring for patients after LVAD implantation is right heart dysfunction. While many scoring systems have been developed to try to anticipate RV failure, the accuracy of these predictive tools remains low. We present a novel approach of implantation of a temporary right ventricular assist devices (RVAD) during LVAD implantation with subsequent weaning in the immediate postoperative period, utilizing a strategy that does not require a return to the operating room for removal of the RVAD cannulas.
Buchanan SA, Langenburg SE, Mauney MC, et al. 1994. Ambulatory intra-aortic balloon counterpulsation. Ann Thorac Surg 58:1547-9.
Cowger J, Sundareswaran K, Rogers JG, et al. 2013. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol 61:313-21.
De Simone V, Cipriani M, Verde A, et al. 2015. Right ventricular failure after left ventricular assist device implantation: the importance of preoperative hemodynamic profile. J Heart Lung Transplant 34:S198.
Fitzpatrick JR, Fredrick JR, Hsu VM, et al. 2008. Risk score from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 27:1286-92.
Gaffey AC, Alturi P. 2015. Post-left ventricular assist device support right ventricular failure: Can it be predicted preoperatively, and should it be a contraindication to implantation? J Thorac Cardiovasc Surg 150:1659-60.
Haneya A, Phillipp A, Puehler T, et al. 2012. Temporary percutaneous, right ventricular, support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac 41:219-23.
Kang G, Hs R, Banerjee D. 2014. Pulmonary artery pulsatility index predicts right ventricular failure after LVAD implantation. J Heart Lung Transplant 33:S86.
Kormos RL, Teuteberg JJ, Pagani FD, et al. 2010. Right ventricular failure in patients with the HeartMate II continuous flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 139:1316-24.
Lazar JF, Schwartz MF, Schiralli MP, et al. 2013. Survival after left ventricular assist device with and without right ventricular support. Ann Thorac Surg 96:2155-9.
Leitz K, Long JW, Khoury AG, et al. 2007. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116:497-505.
Lo C, Murphy D, Summerhayes R, et al. 2015. Right ventricular failure after implantation of continuous flow left ventricular assist device: analysis of predictors and outcomes. Clin Transplant 29:763-70.
Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aronson KD. 2010. Model for end-stage liver disease predicts left ventricular assist device transfusion requirements, morbidity, and mortality. Circulation 121:214-20.
Patil NP, Mohite PN, Sabashnikov A, et al. 2015. Preoperative predictors and outcomes of right ventricular assist device implantation after continuous-flow left ventricular assist device implantation. J Thorac Cardiovasc Surg 150:1651-8.
Patlolla B, Beygui R, Haddad F. 2013. Right-ventricular failure following left ventricle assist device implantation. Curr Opin Cardiol 8:223-33.
Takeda K, Naka Y, Yang JA, et al. 2014. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant 33:141-8.